Skip to main content
Top
Published in: Addiction Science & Clinical Practice 1/2023

Open Access 01-12-2023 | Study Protocol

Promoting alcohol treatment engagement post-hospitalization with brief intervention, medications and CBT4CBT: protocol for a randomized clinical trial in a diverse patient population

Authors: E. Jennifer Edelman, Oscar F. Rojas-Perez, Charla Nich, Joanne Corvino, Tami Frankforter, Derrick Gordon, Ayana Jordan, Manuel Paris, Jr, Melissa B. Weimer, Brian T. Yates, Emily C. Williams, Brian D. Kiluk

Published in: Addiction Science & Clinical Practice | Issue 1/2023

Login to get access

Abstract

Background

Alcohol use disorder (AUD) commonly causes hospitalization, particularly for individuals disproportionately impacted by structural racism and other forms of marginalization. The optimal approach for engaging hospitalized patients with AUD in treatment post-hospital discharge is unknown. We describe the rationale, aims, and protocol for Project ENHANCE (ENhancing Hospital-initiated Alcohol TreatmeNt to InCrease Engagement), a clinical trial testing increasingly intensive approaches using a hybrid type 1 effectiveness-implementation approach.

Methods

We are randomizing English and/or Spanish-speaking individuals with untreated AUD (n = 450) from a large, urban, academic hospital in New Haven, CT to: (1) Brief Negotiation Interview (with referral and telephone booster) alone (BNI), (2) BNI plus facilitated initiation of medications for alcohol use disorder (BNI + MAUD), or (3) BNI + MAUD + initiation of computer-based training for cognitive behavioral therapy (CBT4CBT, BNI + MAUD + CBT4CBT). Interventions are delivered by Health Promotion Advocates. The primary outcome is AUD treatment engagement 34 days post-hospital discharge. Secondary outcomes include AUD treatment engagement 90 days post-discharge and changes in self-reported alcohol use and phosphatidylethanol. Exploratory outcomes include health care utilization. We will explore whether the effectiveness of the interventions on AUD treatment engagement and alcohol use outcomes differ across and within racialized and ethnic groups, consistent with disproportionate impacts of AUD. Lastly, we will conduct an implementation-focused process evaluation, including individual-level collection and statistical comparisons between the three conditions of costs to providers and to patients, cost-effectiveness indices (effectiveness/cost ratios), and cost–benefit indices (benefit/cost ratios, net benefit [benefits minus costs). Graphs of individual- and group-level effectiveness x cost, and benefits x costs, will portray relationships between costs and effectiveness and between costs and benefits for the three conditions, in a manner that community representatives also should be able to understand and use.

Conclusions

Project ENHANCE is expected to generate novel findings to inform future hospital-based efforts to promote AUD treatment engagement among diverse patient populations, including those most impacted by AUD.
Clinical Trial Registration: Clinicaltrials.gov identifier: NCT05338151.
Appendix
Available only for authorised users
Literature
1.
go back to reference Esser MB, Leung G, Sherk A, Bohm MK, Liu Y, Lu H, Naimi TS. Estimated deaths attributable to excessive alcohol use among us adults aged 20 to 64 years, 2015 to 2019. JAMA Netw Open. 2022;5:e2239485.PubMedPubMedCentral Esser MB, Leung G, Sherk A, Bohm MK, Liu Y, Lu H, Naimi TS. Estimated deaths attributable to excessive alcohol use among us adults aged 20 to 64 years, 2015 to 2019. JAMA Netw Open. 2022;5:e2239485.PubMedPubMedCentral
3.
go back to reference Spillane S, Shiels MS, Best AF, Haozous EA, Withrow DR, Chen Y, de Gonzalez AB, Freedman ND. Trends in alcohol-induced deaths in the United States, 2000–2016. JAMA Netw Open. 2020;3:e1921451.PubMedPubMedCentral Spillane S, Shiels MS, Best AF, Haozous EA, Withrow DR, Chen Y, de Gonzalez AB, Freedman ND. Trends in alcohol-induced deaths in the United States, 2000–2016. JAMA Netw Open. 2020;3:e1921451.PubMedPubMedCentral
5.
go back to reference Englander H, King C, Nicolaidis C, Collins D, Patten A, Gregg J, Korthuis PT. Predictors of opioid and alcohol pharmacotherapy initiation at hospital discharge among patients seen by an inpatient addiction consult service. J Addict Med. 2020;14:415–22.PubMedPubMedCentral Englander H, King C, Nicolaidis C, Collins D, Patten A, Gregg J, Korthuis PT. Predictors of opioid and alcohol pharmacotherapy initiation at hospital discharge among patients seen by an inpatient addiction consult service. J Addict Med. 2020;14:415–22.PubMedPubMedCentral
6.
go back to reference Singh JA, Cleveland JD. Trends in hospitalizations for alcohol use disorder in the US from 1998 to 2016. JAMA Netw Open. 2020;3:e2016580.PubMed Singh JA, Cleveland JD. Trends in hospitalizations for alcohol use disorder in the US from 1998 to 2016. JAMA Netw Open. 2020;3:e2016580.PubMed
7.
go back to reference Pollard MS, Tucker JS, Green HD Jr. Changes in adult alcohol use and consequences during the COVID-19 pandemic in the US. JAMA Netw Open. 2020;3:e2022942.PubMedPubMedCentral Pollard MS, Tucker JS, Green HD Jr. Changes in adult alcohol use and consequences during the COVID-19 pandemic in the US. JAMA Netw Open. 2020;3:e2022942.PubMedPubMedCentral
8.
go back to reference Velez CM, Nicolaidis C, Korthuis PT, Englander H. “It’s been an experience, a life learning experience”: a qualitative study of hospitalized patients with substance use disorders. J Gen Intern Med. 2017;32:296–303.PubMed Velez CM, Nicolaidis C, Korthuis PT, Englander H. “It’s been an experience, a life learning experience”: a qualitative study of hospitalized patients with substance use disorders. J Gen Intern Med. 2017;32:296–303.PubMed
9.
go back to reference Makdissi R, Stewart SH. Care for hospitalized patients with unhealthy alcohol use: a narrative review. Addict Sci Clin Pract. 2013;8:11.PubMedPubMedCentral Makdissi R, Stewart SH. Care for hospitalized patients with unhealthy alcohol use: a narrative review. Addict Sci Clin Pract. 2013;8:11.PubMedPubMedCentral
10.
go back to reference Sacco P, Unick GJ, Kuerbis A, Koru AG, Moore AA. Alcohol-related diagnoses in hospital admissions for all causes among middle-aged and older adults: trends and cohort differences from 1993 to 2010. J Aging Health. 2015;27:1358–74.PubMedPubMedCentral Sacco P, Unick GJ, Kuerbis A, Koru AG, Moore AA. Alcohol-related diagnoses in hospital admissions for all causes among middle-aged and older adults: trends and cohort differences from 1993 to 2010. J Aging Health. 2015;27:1358–74.PubMedPubMedCentral
11.
go back to reference Zemore SE, Karriker-Jaffe KJ, Mulia N, Kerr WC, Ehlers CL, Cook WK, Martinez P, Lui C, Greenfield TK. The future of research on alcohol-related disparities across U.S. racial/ethnic groups: a plan of attack. J Stud Alcohol Drugs. 2018;79:7–21.PubMedCentral Zemore SE, Karriker-Jaffe KJ, Mulia N, Kerr WC, Ehlers CL, Cook WK, Martinez P, Lui C, Greenfield TK. The future of research on alcohol-related disparities across U.S. racial/ethnic groups: a plan of attack. J Stud Alcohol Drugs. 2018;79:7–21.PubMedCentral
12.
go back to reference Kiluk BD, Ray LA, Walthers J, Bernstein M, Tonigan JS, Magill M. Technology-delivered cognitive-behavioral interventions for alcohol use: a meta-analysis. Alcohol Clin Exp Res. 2019;43:2285–95.PubMedPubMedCentral Kiluk BD, Ray LA, Walthers J, Bernstein M, Tonigan JS, Magill M. Technology-delivered cognitive-behavioral interventions for alcohol use: a meta-analysis. Alcohol Clin Exp Res. 2019;43:2285–95.PubMedPubMedCentral
13.
go back to reference Englander H, Dobbertin K, Lind BK, Nicolaidis C, Graven P, Dorfman C, Korthuis PT. Inpatient addiction medicine consultation and post-hospital substance use disorder treatment engagement: a propensity-matched analysis. J Gen Intern Med. 2019;34:2796–803.PubMedPubMedCentral Englander H, Dobbertin K, Lind BK, Nicolaidis C, Graven P, Dorfman C, Korthuis PT. Inpatient addiction medicine consultation and post-hospital substance use disorder treatment engagement: a propensity-matched analysis. J Gen Intern Med. 2019;34:2796–803.PubMedPubMedCentral
15.
go back to reference Busch AC, Denduluri M, Glass J, Hetzel S, Gugnani SP, Gassman M, Krahn D, Deyo B, Brown R. Predischarge injectable versus oral naltrexone to improve postdischarge treatment engagement among hospitalized veterans with alcohol use disorder: a randomized pilot proof-of-concept study. Alcohol Clin Exp Res. 2017;41:1352–60.PubMedPubMedCentral Busch AC, Denduluri M, Glass J, Hetzel S, Gugnani SP, Gassman M, Krahn D, Deyo B, Brown R. Predischarge injectable versus oral naltrexone to improve postdischarge treatment engagement among hospitalized veterans with alcohol use disorder: a randomized pilot proof-of-concept study. Alcohol Clin Exp Res. 2017;41:1352–60.PubMedPubMedCentral
16.
go back to reference Kirchoff RW, Mohammed NM, McHugh J, Markota M, Kingsley T, Leung J, Burton MC, Chaudhary R. Naltrexone initiation in the inpatient setting for alcohol use disorder: a systematic review of clinical outcomes. Mayo Clin Proc Innov Qual Outcomes. 2021;5:495–501.PubMedPubMedCentral Kirchoff RW, Mohammed NM, McHugh J, Markota M, Kingsley T, Leung J, Burton MC, Chaudhary R. Naltrexone initiation in the inpatient setting for alcohol use disorder: a systematic review of clinical outcomes. Mayo Clin Proc Innov Qual Outcomes. 2021;5:495–501.PubMedPubMedCentral
17.
go back to reference Terasaki D, Loh R, Cornell A, Taub J, Thurstone C. Single-dose intravenous ketamine or intramuscular naltrexone for high-utilization inpatients with alcohol use disorder: pilot trial feasibility and readmission rates. Addict Sci Clin Pract. 2022;17:64.PubMedPubMedCentral Terasaki D, Loh R, Cornell A, Taub J, Thurstone C. Single-dose intravenous ketamine or intramuscular naltrexone for high-utilization inpatients with alcohol use disorder: pilot trial feasibility and readmission rates. Addict Sci Clin Pract. 2022;17:64.PubMedPubMedCentral
18.
go back to reference Leung JG, Narayanan PP, Markota M, Miller NE, Philbrick KL, Burton MC, Kirchoff RW. Assessing naltrexone prescribing and barriers to initiation for alcohol use disorder: a multidisciplinary. Multisite Surv Front Psychiatry. 2022;13:856938. Leung JG, Narayanan PP, Markota M, Miller NE, Philbrick KL, Burton MC, Kirchoff RW. Assessing naltrexone prescribing and barriers to initiation for alcohol use disorder: a multidisciplinary. Multisite Surv Front Psychiatry. 2022;13:856938.
19.
go back to reference Tigh J, Daniel K, Balasanova AA. Impact of hospital-administered extended-release naltrexone on readmission rates in patients with alcohol use disorder: a pilot study. Prim Care Companion CNS Disord. 2022;24:43569. Tigh J, Daniel K, Balasanova AA. Impact of hospital-administered extended-release naltrexone on readmission rates in patients with alcohol use disorder: a pilot study. Prim Care Companion CNS Disord. 2022;24:43569.
20.
go back to reference Curran GM, Bauer M, Mittman B, Pyne JM, Stetler C. Effectiveness-implementation hybrid designs: combining elements of clinical effectiveness and implementation research to enhance public health impact. Med Care. 2012;50:217–26.PubMedPubMedCentral Curran GM, Bauer M, Mittman B, Pyne JM, Stetler C. Effectiveness-implementation hybrid designs: combining elements of clinical effectiveness and implementation research to enhance public health impact. Med Care. 2012;50:217–26.PubMedPubMedCentral
21.
go back to reference Hagedorn HJ, Stetler CB, Bangerter A, Noorbaloochi S, Stitzer ML, Kivlahan D. An implementation-focused process evaluation of an incentive intervention effectiveness trial in substance use disorders clinics at two Veterans Health Administration medical centers. Addict Sci Clin Pract. 2014;9:12.PubMedPubMedCentral Hagedorn HJ, Stetler CB, Bangerter A, Noorbaloochi S, Stitzer ML, Kivlahan D. An implementation-focused process evaluation of an incentive intervention effectiveness trial in substance use disorders clinics at two Veterans Health Administration medical centers. Addict Sci Clin Pract. 2014;9:12.PubMedPubMedCentral
22.
go back to reference Zemore SE, Ye Y, Mulia N, Martinez P, Jones-Webb R, Karriker-Jaffe K. Poor, persecuted, young, and alone: toward explaining the elevated risk of alcohol problems among Black and Latino men who drink. Drug Alcohol Depend. 2016;163:31–9.PubMedPubMedCentral Zemore SE, Ye Y, Mulia N, Martinez P, Jones-Webb R, Karriker-Jaffe K. Poor, persecuted, young, and alone: toward explaining the elevated risk of alcohol problems among Black and Latino men who drink. Drug Alcohol Depend. 2016;163:31–9.PubMedPubMedCentral
23.
go back to reference Ransome Y, Carty DC, Cogburn CD, Williams DR. Racial disparities in the association between alcohol use disorders and health in black and white women. Biodemography Soc Biol. 2017;63:236–52.PubMedPubMedCentral Ransome Y, Carty DC, Cogburn CD, Williams DR. Racial disparities in the association between alcohol use disorders and health in black and white women. Biodemography Soc Biol. 2017;63:236–52.PubMedPubMedCentral
25.
go back to reference U.S. Department of Health and Human Services. Facing addiction in America: the surgeon general’s report on alcohol, drugs, and health. Washington: HHS; 2016. U.S. Department of Health and Human Services. Facing addiction in America: the surgeon general’s report on alcohol, drugs, and health. Washington: HHS; 2016.
26.
go back to reference Ray LA, Meredith LR, Kiluk BD, Walthers J, Carroll KM, Magill M. Combined pharmacotherapy and cognitive behavioral therapy for adults with alcohol or substance use disorders: a systematic review and meta-analysis. JAMA Netw Open. 2020;3:e208279.PubMedPubMedCentral Ray LA, Meredith LR, Kiluk BD, Walthers J, Carroll KM, Magill M. Combined pharmacotherapy and cognitive behavioral therapy for adults with alcohol or substance use disorders: a systematic review and meta-analysis. JAMA Netw Open. 2020;3:e208279.PubMedPubMedCentral
27.
go back to reference Sholomskas DE, Syracuse-Siewert G, Rounsaville BJ, Ball SA, Nuro KF, Carroll KM. We don’t train in vain: a dissemination trial of three strategies of training clinicians in cognitive-behavioral therapy. J Consult Clin Psychol. 2005;73:106–15.PubMedPubMedCentral Sholomskas DE, Syracuse-Siewert G, Rounsaville BJ, Ball SA, Nuro KF, Carroll KM. We don’t train in vain: a dissemination trial of three strategies of training clinicians in cognitive-behavioral therapy. J Consult Clin Psychol. 2005;73:106–15.PubMedPubMedCentral
28.
go back to reference Greist JH. A promising debut for computerized therapies. Am J Psychiatry. 2008;165:793–5.PubMed Greist JH. A promising debut for computerized therapies. Am J Psychiatry. 2008;165:793–5.PubMed
29.
go back to reference Carroll KM, Rounsaville BJ. Computer-assisted therapy in psychiatry: be brave—it’s a new world. Curr Psychiatry Rep. 2010;12:426–32.PubMedPubMedCentral Carroll KM, Rounsaville BJ. Computer-assisted therapy in psychiatry: be brave—it’s a new world. Curr Psychiatry Rep. 2010;12:426–32.PubMedPubMedCentral
30.
go back to reference Postel MG, de Jong CA, de Haan HA. Does e-therapy for problem drinking reach hidden populations? Am J Psychiatry. 2005;162:2393.PubMed Postel MG, de Jong CA, de Haan HA. Does e-therapy for problem drinking reach hidden populations? Am J Psychiatry. 2005;162:2393.PubMed
31.
go back to reference Marks IM, Cavanagh K. Computer-aided psychological treatments: evolving issues. Annu Rev Clin Psychol. 2009;5:121.PubMed Marks IM, Cavanagh K. Computer-aided psychological treatments: evolving issues. Annu Rev Clin Psychol. 2009;5:121.PubMed
32.
go back to reference McCaul ME, Svikis DS, Moore RD. Predictors of outpatient treatment retention: patient versus substance use characteristics. Drug Alcohol Depend. 2001;62:9–17.PubMed McCaul ME, Svikis DS, Moore RD. Predictors of outpatient treatment retention: patient versus substance use characteristics. Drug Alcohol Depend. 2001;62:9–17.PubMed
33.
go back to reference Matsuzaka S, Knapp M. Anti-racism and substance use treatment: addiction does not discriminate, but do we? J Ethn Subst Abuse. 2020;19:567–93.PubMed Matsuzaka S, Knapp M. Anti-racism and substance use treatment: addiction does not discriminate, but do we? J Ethn Subst Abuse. 2020;19:567–93.PubMed
34.
go back to reference Kiluk BD, Devore KA, Buck MB, Nich C, Frankforter TL, LaPaglia DM, Yates BT, Gordon MA, Carroll KM. Randomized trial of computerized cognitive behavioral therapy for alcohol use disorders: efficacy as a virtual stand-alone and treatment add-on compared with standard outpatient treatment. Alcohol Clin Exp Res. 2016;40:1991–2000.PubMedPubMedCentral Kiluk BD, Devore KA, Buck MB, Nich C, Frankforter TL, LaPaglia DM, Yates BT, Gordon MA, Carroll KM. Randomized trial of computerized cognitive behavioral therapy for alcohol use disorders: efficacy as a virtual stand-alone and treatment add-on compared with standard outpatient treatment. Alcohol Clin Exp Res. 2016;40:1991–2000.PubMedPubMedCentral
35.
go back to reference Paris M, Silva M, Anez-Nava L, Jaramillo Y, Kiluk BD, Gordon MA, Nich C, Frankforter T, Devore K, Ball SA, Carroll KM. Culturally adapted, web-based cognitive behavioral therapy for Spanish-speaking individuals with substance use disorders: a randomized clinical trial. Am J Public Health. 2018;108:1535–42.PubMedPubMedCentral Paris M, Silva M, Anez-Nava L, Jaramillo Y, Kiluk BD, Gordon MA, Nich C, Frankforter T, Devore K, Ball SA, Carroll KM. Culturally adapted, web-based cognitive behavioral therapy for Spanish-speaking individuals with substance use disorders: a randomized clinical trial. Am J Public Health. 2018;108:1535–42.PubMedPubMedCentral
36.
go back to reference King C, Nicolaidis C, Korthuis PT, Priest KC, Englander H. Patterns of substance use before and after hospitalization among patients seen by an inpatient addiction consult service: a latent transition analysis. J Subst Abuse Treat. 2020;118:108121.PubMedPubMedCentral King C, Nicolaidis C, Korthuis PT, Priest KC, Englander H. Patterns of substance use before and after hospitalization among patients seen by an inpatient addiction consult service: a latent transition analysis. J Subst Abuse Treat. 2020;118:108121.PubMedPubMedCentral
37.
go back to reference Jordan A, Quainoo S, Nich C, Babuscio TA, Funaro M, Carroll KM: An evaluation of racial/ethnic disparities in alcohol, cannabis, and illicit substance use treatment initiation, engagement, and treatment outcome: a systematic review of randomized clinical trials. Jordan A, Quainoo S, Nich C, Babuscio TA, Funaro M, Carroll KM: An evaluation of racial/ethnic disparities in alcohol, cannabis, and illicit substance use treatment initiation, engagement, and treatment outcome: a systematic review of randomized clinical trials.
38.
go back to reference Hahn JA, Murnane PM, Vittinghoff E, Muyindike WR, Emenyonu NI, Fatch R, Chamie G, Haberer JE, Francis JM, Kapiga S, et al. Factors associated with phosphatidylethanol (PEth) sensitivity for detecting unhealthy alcohol use: an individual patient data meta-analysis. Alcohol Clin Exp Res. 2021;45:1166–87.PubMedPubMedCentral Hahn JA, Murnane PM, Vittinghoff E, Muyindike WR, Emenyonu NI, Fatch R, Chamie G, Haberer JE, Francis JM, Kapiga S, et al. Factors associated with phosphatidylethanol (PEth) sensitivity for detecting unhealthy alcohol use: an individual patient data meta-analysis. Alcohol Clin Exp Res. 2021;45:1166–87.PubMedPubMedCentral
39.
go back to reference Johansson K, Johansson L, Pennlert J, Soderberg S, Jansson JH, Lind MM. Phosphatidylethanol levels, as a marker of alcohol consumption, are associated with risk of intracerebral hemorrhage. Stroke. 2020;51:2148–52.PubMed Johansson K, Johansson L, Pennlert J, Soderberg S, Jansson JH, Lind MM. Phosphatidylethanol levels, as a marker of alcohol consumption, are associated with risk of intracerebral hemorrhage. Stroke. 2020;51:2148–52.PubMed
40.
go back to reference Edelman EJ, Dziura J, Deng Y, Bold KW, Murphy SM, Porter E, Sigel KM, Yager JE, Ledgerwood DM, Bernstein SL. A SMART approach to treating tobacco use disorder in persons with HIV (SMARTTT): rationale and design for a hybrid type 1 effectiveness-implementation study. Contemp Clin Trials. 2021;110:106379.PubMedPubMedCentral Edelman EJ, Dziura J, Deng Y, Bold KW, Murphy SM, Porter E, Sigel KM, Yager JE, Ledgerwood DM, Bernstein SL. A SMART approach to treating tobacco use disorder in persons with HIV (SMARTTT): rationale and design for a hybrid type 1 effectiveness-implementation study. Contemp Clin Trials. 2021;110:106379.PubMedPubMedCentral
41.
go back to reference Drummond MS, Sculpher MJ, Claxton K, Stoddart GL, Torrance GW. Methods for the economic evaluatoin of health prorgrammers. 4th ed. Oxford: Oxford University Pres; 2015. Drummond MS, Sculpher MJ, Claxton K, Stoddart GL, Torrance GW. Methods for the economic evaluatoin of health prorgrammers. 4th ed. Oxford: Oxford University Pres; 2015.
42.
go back to reference Hornack SE, Yates BT. Costs, benefits, and net benefit of 13 inpatient substance use treatments for 14,947 women and men. Eval Program Plann. 2022;97:102198.PubMed Hornack SE, Yates BT. Costs, benefits, and net benefit of 13 inpatient substance use treatments for 14,947 women and men. Eval Program Plann. 2022;97:102198.PubMed
43.
go back to reference Bush K, Kivlahan DR, McDonell MB, Fihn SD, Bradley KA. The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory care quality improvement project (ACQUIP). Alcohol use disorders identification test. Arch Intern Med. 1998;158:1789–95.PubMed Bush K, Kivlahan DR, McDonell MB, Fihn SD, Bradley KA. The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory care quality improvement project (ACQUIP). Alcohol use disorders identification test. Arch Intern Med. 1998;158:1789–95.PubMed
44.
go back to reference Joudrey PJ, Oldfield BJ, Yonkers KA, O’Connor PG, Berland G, Edelman EJ. Inpatient adoption of medications for alcohol use disorder: a mixed-methods formative evaluation involving key stakeholders. Drug Alcohol Depend. 2020;213:108090.PubMedPubMedCentral Joudrey PJ, Oldfield BJ, Yonkers KA, O’Connor PG, Berland G, Edelman EJ. Inpatient adoption of medications for alcohol use disorder: a mixed-methods formative evaluation involving key stakeholders. Drug Alcohol Depend. 2020;213:108090.PubMedPubMedCentral
45.
go back to reference Hallgren KA, Matson TE, Oliver M, Caldeiro RM, Kivlahan DR, Bradley KA. Practical assessment of DSM-5 alcohol use disorder criteria in routine care: high test-retest reliability of an alcohol symptom checklist. Alcohol Clin Exp Res. 2022;46:458–67.PubMedPubMedCentral Hallgren KA, Matson TE, Oliver M, Caldeiro RM, Kivlahan DR, Bradley KA. Practical assessment of DSM-5 alcohol use disorder criteria in routine care: high test-retest reliability of an alcohol symptom checklist. Alcohol Clin Exp Res. 2022;46:458–67.PubMedPubMedCentral
46.
go back to reference Hallgren KA, Matson TE, Oliver M, Witkiewitz K, Bobb JF, Lee AK, Caldeiro RM, Kivlahan D, Bradley KA. Practical assessment of alcohol use disorder in routine primary care: performance of an alcohol symptom checklist. J Gen Intern Med. 2022;37:1885–93.PubMed Hallgren KA, Matson TE, Oliver M, Witkiewitz K, Bobb JF, Lee AK, Caldeiro RM, Kivlahan D, Bradley KA. Practical assessment of alcohol use disorder in routine primary care: performance of an alcohol symptom checklist. J Gen Intern Med. 2022;37:1885–93.PubMed
47.
go back to reference Donroe JH, Edelman EJ. Alcohol use. Ann Intern Med. 2022;175:ITC145–60.PubMed Donroe JH, Edelman EJ. Alcohol use. Ann Intern Med. 2022;175:ITC145–60.PubMed
48.
go back to reference Stout RL, Wirtz PW, Carbonari JP, DelBoca FK. Ensuring balanced distribution of prognostic factors in treatment outcome research. J Stud Alcohol. 1994;Supplement 12:70–5. Stout RL, Wirtz PW, Carbonari JP, DelBoca FK. Ensuring balanced distribution of prognostic factors in treatment outcome research. J Stud Alcohol. 1994;Supplement 12:70–5.
49.
go back to reference Wei LJ. An application of an urn model to the design of sequential controlled clinical trials. J Am Stat Assoc. 1978;73:559–63. Wei LJ. An application of an urn model to the design of sequential controlled clinical trials. J Am Stat Assoc. 1978;73:559–63.
50.
go back to reference Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O’Neal L, McLeod L, Delacqua G, Delacqua F, Kirby J, et al. The REDCap consortium: Building an international community of software platform partners. J Biomed Inform. 2019;95:103208.PubMedPubMedCentral Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O’Neal L, McLeod L, Delacqua G, Delacqua F, Kirby J, et al. The REDCap consortium: Building an international community of software platform partners. J Biomed Inform. 2019;95:103208.PubMedPubMedCentral
51.
go back to reference National Committee for Quality Assurance. Initiation and engagement of alcohol and other drug abuse or dependence treatment (IET). National Committee for Quality Assurance. Initiation and engagement of alcohol and other drug abuse or dependence treatment (IET).
52.
go back to reference Harris AH, Humphreys K, Bowe T, Tiet Q, Finney JW. Does meeting the HEDIS substance abuse treatment engagement criterion predict patient outcomes? J Behav Health Serv Res. 2010;37:25–39.PubMed Harris AH, Humphreys K, Bowe T, Tiet Q, Finney JW. Does meeting the HEDIS substance abuse treatment engagement criterion predict patient outcomes? J Behav Health Serv Res. 2010;37:25–39.PubMed
53.
go back to reference D’Onofrio G, O’Connor PG, Pantalon MV, Chawarski MC, Busch SH, Owens PH, Bernstein SL, Fiellin DA. Emergency department-initiated buprenorphine/naloxone treatment for opioid dependence: a randomized clinical trial. JAMA. 2015;313:1636–44.PubMedPubMedCentral D’Onofrio G, O’Connor PG, Pantalon MV, Chawarski MC, Busch SH, Owens PH, Bernstein SL, Fiellin DA. Emergency department-initiated buprenorphine/naloxone treatment for opioid dependence: a randomized clinical trial. JAMA. 2015;313:1636–44.PubMedPubMedCentral
54.
go back to reference D’Onofrio G, Edelman EJ, Hawk KF, Pantalon MV, Chawarski MC, Owens PH, Martel SH, Van Veldhuisen P, Oden N, Murphy SM, et al. Implementation facilitation to promote emergency department-initiated buprenorphine for opioid use disorder: protocol for a hybrid type III effectiveness-implementation study (Project ED HEALTH). Implement Sci. 2019;14:48.PubMedPubMedCentral D’Onofrio G, Edelman EJ, Hawk KF, Pantalon MV, Chawarski MC, Owens PH, Martel SH, Van Veldhuisen P, Oden N, Murphy SM, et al. Implementation facilitation to promote emergency department-initiated buprenorphine for opioid use disorder: protocol for a hybrid type III effectiveness-implementation study (Project ED HEALTH). Implement Sci. 2019;14:48.PubMedPubMedCentral
56.
go back to reference Mee-Lee DE. The ASAM criteria: treatment criteria for addictive, substance-related, and co-occurring conditions. Rockville: American Society of Addiction Medicine; 2013. Mee-Lee DE. The ASAM criteria: treatment criteria for addictive, substance-related, and co-occurring conditions. Rockville: American Society of Addiction Medicine; 2013.
58.
go back to reference Yates BT. Cost-inclusive research on health psychology interventions: why, how, and what next. Health Psychol. 2023;42:139–50.PubMed Yates BT. Cost-inclusive research on health psychology interventions: why, how, and what next. Health Psychol. 2023;42:139–50.PubMed
59.
go back to reference O’Connor EA, Perdue LA, Senger CA, Rushkin M, Patnode CD, Bean SI, Jonas DE. Screening and behavioral counseling interventions to reduce unhealthy alcohol use in adolescents and adults: updated evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2018;320:1910–28.PubMed O’Connor EA, Perdue LA, Senger CA, Rushkin M, Patnode CD, Bean SI, Jonas DE. Screening and behavioral counseling interventions to reduce unhealthy alcohol use in adolescents and adults: updated evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2018;320:1910–28.PubMed
60.
go back to reference Whitlock EP, Polen MR, Green CA, Orleans T, Klein J. Behavioral counseling interventions in primary care to reduce risky/harmful alcohol use by adults: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2004;140:557–68.PubMed Whitlock EP, Polen MR, Green CA, Orleans T, Klein J. Behavioral counseling interventions in primary care to reduce risky/harmful alcohol use by adults: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2004;140:557–68.PubMed
61.
go back to reference Barry DT, Moore BA, Pantalon MV, Chawarski MC, Sullivan LE, O’Connor PG, Schottenfeld RS, Fiellin DA. Patient satisfaction with primary care office-based buprenorphine/naloxone treatment. J Gen Intern Med. 2007;22:242–5.PubMedPubMedCentral Barry DT, Moore BA, Pantalon MV, Chawarski MC, Sullivan LE, O’Connor PG, Schottenfeld RS, Fiellin DA. Patient satisfaction with primary care office-based buprenorphine/naloxone treatment. J Gen Intern Med. 2007;22:242–5.PubMedPubMedCentral
62.
go back to reference D’Onofrio G, Fiellin DA, Pantalon MV, Chawarski MC, Owens PH, Degutis LC, Busch SH, Bernstein SL, O’Connor PG. A brief intervention reduces hazardous and harmful drinking in emergency department patients. Ann Emerg Med. 2012;60:181–92.PubMed D’Onofrio G, Fiellin DA, Pantalon MV, Chawarski MC, Owens PH, Degutis LC, Busch SH, Bernstein SL, O’Connor PG. A brief intervention reduces hazardous and harmful drinking in emergency department patients. Ann Emerg Med. 2012;60:181–92.PubMed
63.
go back to reference D’Onofrio G, Pantalon MV, Degutis LC, Fiellin DA, Busch SH, Chawarski MC, Owens PH, O’Connor PG. Brief intervention for hazardous and harmful drinkers in the emergency department. Ann Emerg Med. 2008;51(742–750):e742. D’Onofrio G, Pantalon MV, Degutis LC, Fiellin DA, Busch SH, Chawarski MC, Owens PH, O’Connor PG. Brief intervention for hazardous and harmful drinkers in the emergency department. Ann Emerg Med. 2008;51(742–750):e742.
64.
go back to reference D’Onofrio G, Pantalon MV, Degutis LC, Fiellin DA, O’Connor PG. Development and implementation of an emergency practitioner-performed brief intervention for hazardous and harmful drinkers in the emergency department. Acad Emerg Med. 2005;12:249–56.PubMedPubMedCentral D’Onofrio G, Pantalon MV, Degutis LC, Fiellin DA, O’Connor PG. Development and implementation of an emergency practitioner-performed brief intervention for hazardous and harmful drinkers in the emergency department. Acad Emerg Med. 2005;12:249–56.PubMedPubMedCentral
65.
go back to reference D’Onofrio G, Fiellin DA, Pantalon MV, Chawarski MC, Owens PH, Degutis LC, Busch SH, Bernstein SL, O’Connor PG. A brief intervention reduces hazardous and harmful drinking in emergency department patients. Ann Emerg Med. 2012;60:181–92.PubMed D’Onofrio G, Fiellin DA, Pantalon MV, Chawarski MC, Owens PH, Degutis LC, Busch SH, Bernstein SL, O’Connor PG. A brief intervention reduces hazardous and harmful drinking in emergency department patients. Ann Emerg Med. 2012;60:181–92.PubMed
66.
go back to reference Connors GJ, DiClemente CC, Velasquez MM, Donovan DM. Substance abuse treatment and the stages of change: selecting and planning interventions. New York: Guilford Press; 2013. Connors GJ, DiClemente CC, Velasquez MM, Donovan DM. Substance abuse treatment and the stages of change: selecting and planning interventions. New York: Guilford Press; 2013.
67.
go back to reference Edelman EJ, Dinh A, Radulescu R, Lurie B, D’Onofrio G, Tetrault JM, Fiellin DA, Fiellin LE. Combining rapid HIV testing and a brief alcohol intervention in young unhealthy drinkers in the emergency department: a pilot study. Am J Drug Alcohol Abuse. 2012;38:539–43.PubMedPubMedCentral Edelman EJ, Dinh A, Radulescu R, Lurie B, D’Onofrio G, Tetrault JM, Fiellin DA, Fiellin LE. Combining rapid HIV testing and a brief alcohol intervention in young unhealthy drinkers in the emergency department: a pilot study. Am J Drug Alcohol Abuse. 2012;38:539–43.PubMedPubMedCentral
68.
go back to reference Edelman EJ, Maisto SA, Hansen NB, Cutter CJ, Dziura J, Fiellin LE, O’Connor PG, Bedimo R, Gibert C, Marconi VC, et al. The starting treatment for ethanol in primary care trials (STEP Trials): protocol for three parallel multi-site stepped care effectiveness studies for unhealthy alcohol use in HIV-positive patients. Contemp Clin Trials. 2017;52:80–90.PubMed Edelman EJ, Maisto SA, Hansen NB, Cutter CJ, Dziura J, Fiellin LE, O’Connor PG, Bedimo R, Gibert C, Marconi VC, et al. The starting treatment for ethanol in primary care trials (STEP Trials): protocol for three parallel multi-site stepped care effectiveness studies for unhealthy alcohol use in HIV-positive patients. Contemp Clin Trials. 2017;52:80–90.PubMed
69.
go back to reference Joint Commission. Specifications manual for Joint Commission National Quality Core Measures (2010A1). Joint Commission. Specifications manual for Joint Commission National Quality Core Measures (2010A1).
70.
go back to reference Substance Abuse and Mental Health Services Administration and National Institute on Alcohol Abuse and Alcoholism. Medication for the treatment of alcohol use disorder: a brief guide (Substance Abuse and Mental Health Services Administration ed., HHS Publication No. (SMA) 15-4907 edition. Rockville; 2015. Substance Abuse and Mental Health Services Administration and National Institute on Alcohol Abuse and Alcoholism. Medication for the treatment of alcohol use disorder: a brief guide (Substance Abuse and Mental Health Services Administration ed., HHS Publication No. (SMA) 15-4907 edition. Rockville; 2015.
72.
go back to reference Kadden R, Carroll KM, Donovan D, Cooney JL, Monti P, Abrams D, Litt M, Hester RK. Cognitive-behavioral coping skills therapy manual: a clinical research guide for therapists treating individuals with alcohol abuse and dependence. Rockville: NIAAA; 1992. Kadden R, Carroll KM, Donovan D, Cooney JL, Monti P, Abrams D, Litt M, Hester RK. Cognitive-behavioral coping skills therapy manual: a clinical research guide for therapists treating individuals with alcohol abuse and dependence. Rockville: NIAAA; 1992.
73.
go back to reference Carroll KM, Ball SA, Martino S, Nich C, Babuscio T, Gordon MA, Portnoy GA, Rounsaville BJ. Computer-assisted cognitive-behavioral therapy for addiction: a randomized clinical trial of ‘CBT4CBT.’ Am J Psychiatry. 2008;165:881–8.PubMedPubMedCentral Carroll KM, Ball SA, Martino S, Nich C, Babuscio T, Gordon MA, Portnoy GA, Rounsaville BJ. Computer-assisted cognitive-behavioral therapy for addiction: a randomized clinical trial of ‘CBT4CBT.’ Am J Psychiatry. 2008;165:881–8.PubMedPubMedCentral
74.
go back to reference Carroll KM, Kiluk BD, Nich C, Gordon MA, Portnoy G, Marino D, Ball SA. Computer-assisted delivery of cognitive-behavioral therapy: efficacy and durability of CBT4CBT among cocaine-dependent individuals maintained on methadone. Am J Psychiatry. 2014;171:436–44.PubMedPubMedCentral Carroll KM, Kiluk BD, Nich C, Gordon MA, Portnoy G, Marino D, Ball SA. Computer-assisted delivery of cognitive-behavioral therapy: efficacy and durability of CBT4CBT among cocaine-dependent individuals maintained on methadone. Am J Psychiatry. 2014;171:436–44.PubMedPubMedCentral
75.
go back to reference Carroll KM, Nich C, DeVito EE, Shi JM, Sofuoglu M. Galantamine and computerized cognitive behavioral therapy for cocaine dependence: a randomized clinical trial. J Clin Psychiatry. 2017;79:17m11669. Carroll KM, Nich C, DeVito EE, Shi JM, Sofuoglu M. Galantamine and computerized cognitive behavioral therapy for cocaine dependence: a randomized clinical trial. J Clin Psychiatry. 2017;79:17m11669.
76.
go back to reference Kiluk BD, Nich C, Buck MB, Devore KA, Frankforter TL, LaPaglia DM, Muvvala SB, Carroll KM. Randomized clinical trial of computerized and clinician-delivered CBT in comparison with standard outpatient treatment for substance use disorders: primary within-treatment and follow-up outcomes. Am J Psychiatry. 2018;175:853–63.PubMedPubMedCentral Kiluk BD, Nich C, Buck MB, Devore KA, Frankforter TL, LaPaglia DM, Muvvala SB, Carroll KM. Randomized clinical trial of computerized and clinician-delivered CBT in comparison with standard outpatient treatment for substance use disorders: primary within-treatment and follow-up outcomes. Am J Psychiatry. 2018;175:853–63.PubMedPubMedCentral
77.
go back to reference Tetrault JM, Holt SR, Cavallo DA, O’Connor PG, Gordon MA, Corvino JK, Nich C, Carroll KM. Computerized cognitive behavioral therapy for substance use disorders in a specialized primary care practice: a randomized feasibility trial to address the RT component of SBIRT. J Addict Med. 2020;14:e303–9.PubMed Tetrault JM, Holt SR, Cavallo DA, O’Connor PG, Gordon MA, Corvino JK, Nich C, Carroll KM. Computerized cognitive behavioral therapy for substance use disorders in a specialized primary care practice: a randomized feasibility trial to address the RT component of SBIRT. J Addict Med. 2020;14:e303–9.PubMed
78.
go back to reference Shi JM, Henry SP, Dwy SL, Orazietti SA, Carroll KM. Randomized pilot trial of Web-based cognitive-behavioral therapy adapted for use in office-based buprenorphine maintenance. Subst Abus. 2019;40:132–5.PubMedPubMedCentral Shi JM, Henry SP, Dwy SL, Orazietti SA, Carroll KM. Randomized pilot trial of Web-based cognitive-behavioral therapy adapted for use in office-based buprenorphine maintenance. Subst Abus. 2019;40:132–5.PubMedPubMedCentral
79.
go back to reference Foxcroft DR, Coombes L, Wood S, Allen D, Almeida Santimano NM. Motivational interviewing for alcohol misuse in young adults. Cochrane Database Syst Rev. 2014;8:CD007025. Foxcroft DR, Coombes L, Wood S, Allen D, Almeida Santimano NM. Motivational interviewing for alcohol misuse in young adults. Cochrane Database Syst Rev. 2014;8:CD007025.
80.
go back to reference Lee CS, Lopez SR, Colby SM, Rohsenow D, Hernandez L, Borrelli B, Caetano R. Culturally adapted motivational interviewing for Latino heavy drinkers: results from a randomized clinical trial. J Ethn Subst Abuse. 2013;12:356–73.PubMedPubMedCentral Lee CS, Lopez SR, Colby SM, Rohsenow D, Hernandez L, Borrelli B, Caetano R. Culturally adapted motivational interviewing for Latino heavy drinkers: results from a randomized clinical trial. J Ethn Subst Abuse. 2013;12:356–73.PubMedPubMedCentral
81.
go back to reference Lundahl BW, Kunz C, Brownell C, Tollefson D, Burke BL. A meta-analysis of motivational interviewing: twenty-five years of empirical studies. Res Soc Work Pract. 2010;20:137–60. Lundahl BW, Kunz C, Brownell C, Tollefson D, Burke BL. A meta-analysis of motivational interviewing: twenty-five years of empirical studies. Res Soc Work Pract. 2010;20:137–60.
82.
go back to reference VanBuskirk KA, Wetherell JL. Motivational interviewing with primary care populations: a systematic review and meta-analysis. J Behav Med. 2014;37:768–80.PubMed VanBuskirk KA, Wetherell JL. Motivational interviewing with primary care populations: a systematic review and meta-analysis. J Behav Med. 2014;37:768–80.PubMed
83.
go back to reference Rahm AK, Boggs JM, Martin C, Price DW, Beck A, Backer TE, Dearing JW. Facilitators and barriers to implementing screening, brief intervention, and referral to treatment (SBIRT) in primary care in integrated health care settings. Subst Abus. 2015;36:281–8.PubMed Rahm AK, Boggs JM, Martin C, Price DW, Beck A, Backer TE, Dearing JW. Facilitators and barriers to implementing screening, brief intervention, and referral to treatment (SBIRT) in primary care in integrated health care settings. Subst Abus. 2015;36:281–8.PubMed
84.
go back to reference Bernstein E, Bernstein J, Feldman J, Fernandez W, Hagan M, Mitchell P, Safi C, Woolard R, Mello M, Baird J, et al. An evidence based alcohol screening, brief intervention and referral to treatment (SBIRT) curriculum for emergency department (ED) providers improves skills and utilization. Subst Abus. 2007;28:79–92.PubMedPubMedCentral Bernstein E, Bernstein J, Feldman J, Fernandez W, Hagan M, Mitchell P, Safi C, Woolard R, Mello M, Baird J, et al. An evidence based alcohol screening, brief intervention and referral to treatment (SBIRT) curriculum for emergency department (ED) providers improves skills and utilization. Subst Abus. 2007;28:79–92.PubMedPubMedCentral
85.
go back to reference Nich C, Carroll KM. Now you see it, now you don’t: a practical demonstration of random regression versus traditional ANOVA models in the analysis of longitudinal follow-up data from a clinical trial. J Consult Clin Psychol. 1997;65:252–61.PubMed Nich C, Carroll KM. Now you see it, now you don’t: a practical demonstration of random regression versus traditional ANOVA models in the analysis of longitudinal follow-up data from a clinical trial. J Consult Clin Psychol. 1997;65:252–61.PubMed
86.
go back to reference Nich C, Carroll KM. Intention to treat meets missing data: implications of alternate strategies for analyzing clinical trials data. Drug Alcohol Depend. 2002;68:121–30.PubMedPubMedCentral Nich C, Carroll KM. Intention to treat meets missing data: implications of alternate strategies for analyzing clinical trials data. Drug Alcohol Depend. 2002;68:121–30.PubMedPubMedCentral
87.
go back to reference Afshar M, Burnham EL, Joyce C, Clark BJ, Yong M, Gaydos J, Cooper RS, Smith GS, Kovacs EJ, Lowery EM. Cut-point levels of phosphatidylethanol to identify alcohol misuse in a mixed cohort including critically Ill patients. Alcohol Clin Exp Res. 2017;41:1745–53.PubMedPubMedCentral Afshar M, Burnham EL, Joyce C, Clark BJ, Yong M, Gaydos J, Cooper RS, Smith GS, Kovacs EJ, Lowery EM. Cut-point levels of phosphatidylethanol to identify alcohol misuse in a mixed cohort including critically Ill patients. Alcohol Clin Exp Res. 2017;41:1745–53.PubMedPubMedCentral
89.
go back to reference Burlew AK, Feaster D, Brecht ML, Hubbard R. Measurement and data analysis in research addressing health disparities in substance abuse. J Subst Abuse Treat. 2009;36:25–43.PubMed Burlew AK, Feaster D, Brecht ML, Hubbard R. Measurement and data analysis in research addressing health disparities in substance abuse. J Subst Abuse Treat. 2009;36:25–43.PubMed
90.
go back to reference Burlew AK, Weekes JC, Montgomery L, Feaster DJ, Robbins MS, Rosa CL, Ruglass LM, Venner KL, Wu LT. Conducting research with racial/ethnic minorities: methodological lessons from the NIDA clinical trials network. Am J Drug Alcohol Abuse. 2011;37:324–32.PubMedPubMedCentral Burlew AK, Weekes JC, Montgomery L, Feaster DJ, Robbins MS, Rosa CL, Ruglass LM, Venner KL, Wu LT. Conducting research with racial/ethnic minorities: methodological lessons from the NIDA clinical trials network. Am J Drug Alcohol Abuse. 2011;37:324–32.PubMedPubMedCentral
91.
go back to reference Burlew AK. Alternative approaches to racial/ethnic research. J Ethn Subst Abuse. 2019;18:1–2.PubMed Burlew AK. Alternative approaches to racial/ethnic research. J Ethn Subst Abuse. 2019;18:1–2.PubMed
92.
go back to reference Sung ML, Viera A, Esserman D, Tong G, Davidson D, Aiudi S, Bailey GL, Buchanan AL, Buchelli M, Jenkins M, et al. Contingency management and pre-exposure prophylaxis adherence support services (CoMPASS): a hybrid type 1 effectiveness-implementation study to promote HIV risk reduction among people who inject drugs. Contemp Clin Trials. 2022;125:107037.PubMed Sung ML, Viera A, Esserman D, Tong G, Davidson D, Aiudi S, Bailey GL, Buchanan AL, Buchelli M, Jenkins M, et al. Contingency management and pre-exposure prophylaxis adherence support services (CoMPASS): a hybrid type 1 effectiveness-implementation study to promote HIV risk reduction among people who inject drugs. Contemp Clin Trials. 2022;125:107037.PubMed
93.
go back to reference Gaglio B, Shoup JA, Glasgow RE. The RE-AIM framework: a systematic review of use over time. Am J Public Health. 2013;103:e38-46.PubMedPubMedCentral Gaglio B, Shoup JA, Glasgow RE. The RE-AIM framework: a systematic review of use over time. Am J Public Health. 2013;103:e38-46.PubMedPubMedCentral
94.
go back to reference Glasgow RE, McKay HG, Piette JD, Reynolds KD. The RE-AIM framework for evaluating interventions: what can it tell us about approaches to chronic illness management? Patient Educ Couns. 2001;44:119–27.PubMed Glasgow RE, McKay HG, Piette JD, Reynolds KD. The RE-AIM framework for evaluating interventions: what can it tell us about approaches to chronic illness management? Patient Educ Couns. 2001;44:119–27.PubMed
95.
go back to reference Shelton RC, Chambers DA, Glasgow RE. An extension of RE-AIM to enhance sustainability: addressing dynamic context and promoting health equity over time. Front Public Health. 2020;8:134.PubMedPubMedCentral Shelton RC, Chambers DA, Glasgow RE. An extension of RE-AIM to enhance sustainability: addressing dynamic context and promoting health equity over time. Front Public Health. 2020;8:134.PubMedPubMedCentral
96.
go back to reference Hasin DS, Aharonovich E, O’Leary A, Greenstein E, Pavlicova M, Arunajadai S, Waxman R, Wainberg M, Helzer J, Johnston B. Reducing heavy drinking in HIV primary care: a randomized trial of brief intervention, with and without technological enhancement. Addiction. 2013;108:1230–40.PubMedPubMedCentral Hasin DS, Aharonovich E, O’Leary A, Greenstein E, Pavlicova M, Arunajadai S, Waxman R, Wainberg M, Helzer J, Johnston B. Reducing heavy drinking in HIV primary care: a randomized trial of brief intervention, with and without technological enhancement. Addiction. 2013;108:1230–40.PubMedPubMedCentral
97.
go back to reference Hamilton FL, Hornby J, Sheringham J, Linke S, Ashton C, Moore K, Stevenson F, Murray E. DIAMOND (DIgital Alcohol Management ON Demand): a mixed methods feasibility RCT and embedded process evaluation of a digital health intervention to reduce hazardous and harmful alcohol use. Pilot Feasibility Stud. 2017;3:34.PubMedPubMedCentral Hamilton FL, Hornby J, Sheringham J, Linke S, Ashton C, Moore K, Stevenson F, Murray E. DIAMOND (DIgital Alcohol Management ON Demand): a mixed methods feasibility RCT and embedded process evaluation of a digital health intervention to reduce hazardous and harmful alcohol use. Pilot Feasibility Stud. 2017;3:34.PubMedPubMedCentral
98.
go back to reference Vaca FE, Dziura J, Abujarad F, Pantalon M, Hsiao A, Reynolds J, Maciejewski KR, Field CA, D’Onofrio G. Use of an automated bilingual digital health tool to reduce unhealthy alcohol use among Latino emergency department patients: a randomized clinical trial. JAMA Netw Open. 2023;6:e2314848.PubMedPubMedCentral Vaca FE, Dziura J, Abujarad F, Pantalon M, Hsiao A, Reynolds J, Maciejewski KR, Field CA, D’Onofrio G. Use of an automated bilingual digital health tool to reduce unhealthy alcohol use among Latino emergency department patients: a randomized clinical trial. JAMA Netw Open. 2023;6:e2314848.PubMedPubMedCentral
99.
go back to reference Eyawo O, Deng Y, Dziura J, Justice AC, McGinnis K, Tate JP, Rodriguez-Barradas MC, Hansen NB, Maisto SA, Marconi VC, et al. Validating self-reported unhealthy alcohol use with phosphatidylethanol (PEth) among patients with HIV. Alcohol Clin Exp Res. 2020;44(10):2053–63.PubMedPubMedCentral Eyawo O, Deng Y, Dziura J, Justice AC, McGinnis K, Tate JP, Rodriguez-Barradas MC, Hansen NB, Maisto SA, Marconi VC, et al. Validating self-reported unhealthy alcohol use with phosphatidylethanol (PEth) among patients with HIV. Alcohol Clin Exp Res. 2020;44(10):2053–63.PubMedPubMedCentral
100.
go back to reference Baral S, Logie CH, Grosso A, Wirtz AL, Beyrer C. Modified social ecological model: a tool to guide the assessment of the risks and risk contexts of HIV epidemics. BMC Public Health. 2013;13:482.PubMedPubMedCentral Baral S, Logie CH, Grosso A, Wirtz AL, Beyrer C. Modified social ecological model: a tool to guide the assessment of the risks and risk contexts of HIV epidemics. BMC Public Health. 2013;13:482.PubMedPubMedCentral
101.
go back to reference Edelman EJ, Cole CA, Richardson W, Boshnack N, Jenkins H, Rosenthal MS. Stigma, substance use and sexual risk behaviors among HIV-infected men who have sex with men: a qualitative study. Prev Med Rep. 2016;3:296–302.PubMedPubMedCentral Edelman EJ, Cole CA, Richardson W, Boshnack N, Jenkins H, Rosenthal MS. Stigma, substance use and sexual risk behaviors among HIV-infected men who have sex with men: a qualitative study. Prev Med Rep. 2016;3:296–302.PubMedPubMedCentral
102.
go back to reference Cowan E, Khan MR, Shastry S, Edelman EJ. Conceptualizing the effects of the COVID-19 pandemic on people with opioid use disorder: an application of the social ecological model. Addict Sci Clin Pract. 2021;16:4.PubMedPubMedCentral Cowan E, Khan MR, Shastry S, Edelman EJ. Conceptualizing the effects of the COVID-19 pandemic on people with opioid use disorder: an application of the social ecological model. Addict Sci Clin Pract. 2021;16:4.PubMedPubMedCentral
103.
go back to reference Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V, Collin I, Cummings JL, Chertkow H. The Montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53:695–9.PubMed Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V, Collin I, Cummings JL, Chertkow H. The Montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53:695–9.PubMed
104.
go back to reference Sangha O, Stucki G, Liang MH, Fossel AH, Katz JN. The self-administered comorbidity questionnaire: a new method to assess comorbidity for clinical and health services research. Arthritis Rheum. 2003;49:156–63.PubMed Sangha O, Stucki G, Liang MH, Fossel AH, Katz JN. The self-administered comorbidity questionnaire: a new method to assess comorbidity for clinical and health services research. Arthritis Rheum. 2003;49:156–63.PubMed
106.
go back to reference Wilson IB, Tie Y, Padilla M, Rogers WH, Beer L. Performance of a short, self-report adherence scale in a probability sample of persons using HIV antiretroviral therapy in the United States. AIDS. 2020;34:2239–47.PubMed Wilson IB, Tie Y, Padilla M, Rogers WH, Beer L. Performance of a short, self-report adherence scale in a probability sample of persons using HIV antiretroviral therapy in the United States. AIDS. 2020;34:2239–47.PubMed
107.
go back to reference Wilson IB, Lee Y, Michaud J, Fowler FJ Jr, Rogers WH. Validation of a new three-item self-report measure for medication adherence. AIDS Behav. 2016;20:2700–8.PubMedPubMedCentral Wilson IB, Lee Y, Michaud J, Fowler FJ Jr, Rogers WH. Validation of a new three-item self-report measure for medication adherence. AIDS Behav. 2016;20:2700–8.PubMedPubMedCentral
108.
go back to reference Hanmer J, Dewitt B, Yu L, Tsevat J, Roberts M, Revicki D, Pilkonis PA, Hess R, Hays RD, Fischhoff B, et al. Cross-sectional validation of the PROMIS-Preference scoring system. PLoS ONE. 2018;13:e0201093.PubMedPubMedCentral Hanmer J, Dewitt B, Yu L, Tsevat J, Roberts M, Revicki D, Pilkonis PA, Hess R, Hays RD, Fischhoff B, et al. Cross-sectional validation of the PROMIS-Preference scoring system. PLoS ONE. 2018;13:e0201093.PubMedPubMedCentral
109.
go back to reference Sobell LC, Sobell SM. Alcohol timeline followback (TLFB); handbook of psychiatric measures. Washington: American Psychiatric Association; 1996. Sobell LC, Sobell SM. Alcohol timeline followback (TLFB); handbook of psychiatric measures. Washington: American Psychiatric Association; 1996.
110.
go back to reference Timko C, Moos RH, Finney JW, Connell EG. Gender differences in help-utilization and the 8-year course of alcohol abuse. Addiction. 2002;97:877–89.PubMed Timko C, Moos RH, Finney JW, Connell EG. Gender differences in help-utilization and the 8-year course of alcohol abuse. Addiction. 2002;97:877–89.PubMed
111.
go back to reference Viel G, Boscolo-Berto R, Cecchetto G, Fais P, Nalesso A, Ferrara SD. Phosphatidylethanol in blood as a marker of chronic alcohol use: a systematic review and meta-analysis. Int J Mol Sci. 2012;13:14788–812.PubMedPubMedCentral Viel G, Boscolo-Berto R, Cecchetto G, Fais P, Nalesso A, Ferrara SD. Phosphatidylethanol in blood as a marker of chronic alcohol use: a systematic review and meta-analysis. Int J Mol Sci. 2012;13:14788–812.PubMedPubMedCentral
112.
go back to reference Lieberman DZ, Cioletti A, Massey SH, Collantes RS, Moore BB. Treatment preferences among problem drinkers in primary care. Int J Psychiatry Med. 2014;47:231–40.PubMed Lieberman DZ, Cioletti A, Massey SH, Collantes RS, Moore BB. Treatment preferences among problem drinkers in primary care. Int J Psychiatry Med. 2014;47:231–40.PubMed
113.
go back to reference Stewart SH, Connors GJ. Interest in pharmacotherapy and primary care alcoholism treatment among medically hospitalized, alcohol dependent patients. J Addict Dis. 2007;26:63–9.PubMed Stewart SH, Connors GJ. Interest in pharmacotherapy and primary care alcoholism treatment among medically hospitalized, alcohol dependent patients. J Addict Dis. 2007;26:63–9.PubMed
114.
go back to reference DiClemente CC, Carbonari JP, Montgomery RP, Hughes SO. The alcohol abstinence self-efficacy scale. J Stud Alcohol. 1994;55:141–8.PubMed DiClemente CC, Carbonari JP, Montgomery RP, Hughes SO. The alcohol abstinence self-efficacy scale. J Stud Alcohol. 1994;55:141–8.PubMed
115.
go back to reference Kiluk BD, Dreifuss JA, Weiss RD, Morgenstern J, Carroll KM. The short inventory of problems-revised (SIP-R): psychometric properties within a large, diverse sample of substance use disorder treatment seekers. Psychol Addict Behav. 2013;27:307–14.PubMed Kiluk BD, Dreifuss JA, Weiss RD, Morgenstern J, Carroll KM. The short inventory of problems-revised (SIP-R): psychometric properties within a large, diverse sample of substance use disorder treatment seekers. Psychol Addict Behav. 2013;27:307–14.PubMed
116.
go back to reference American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Washington: American Psychiatric Press; 2013. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Washington: American Psychiatric Press; 2013.
117.
go back to reference Ali R, Meena S, Eastwood B, Richards I, Marsden J. Ultra-rapid screening for substance-use disorders: the alcohol, smoking and substance involvement screening test (ASSIST-Lite). Drug Alcohol Depend. 2013;132:352–61.PubMed Ali R, Meena S, Eastwood B, Richards I, Marsden J. Ultra-rapid screening for substance-use disorders: the alcohol, smoking and substance involvement screening test (ASSIST-Lite). Drug Alcohol Depend. 2013;132:352–61.PubMed
119.
go back to reference Mujahid MS, Diez Roux AV, Morenoff JD, Raghunathan T. Assessing the measurement properties of neighborhood scales: from psychometrics to ecometrics. Am J Epidemiol. 2007;165:858–67.PubMed Mujahid MS, Diez Roux AV, Morenoff JD, Raghunathan T. Assessing the measurement properties of neighborhood scales: from psychometrics to ecometrics. Am J Epidemiol. 2007;165:858–67.PubMed
120.
go back to reference Thompson HS, Valdimarsdottir HB, Winkel G, Jandorf L, Redd W. The group-based medical mistrust scale: psychometric properties and association with breast cancer screening. Prev Med. 2004;38:209–18.PubMed Thompson HS, Valdimarsdottir HB, Winkel G, Jandorf L, Redd W. The group-based medical mistrust scale: psychometric properties and association with breast cancer screening. Prev Med. 2004;38:209–18.PubMed
121.
go back to reference Williams DR, Yan Y, Jackson JS, Anderson NB. Racial differences in physical and mental health: socio-economic status, stress and discrimination. J Health Psychol. 1997;2:335–51.PubMed Williams DR, Yan Y, Jackson JS, Anderson NB. Racial differences in physical and mental health: socio-economic status, stress and discrimination. J Health Psychol. 1997;2:335–51.PubMed
122.
go back to reference Pew Hispanic Center: Pew Hispanic Center Poll: 2007 National Survey of Latinos. (International Communications R ed., 2nd ed. Cornell University, Ithaca, NY: Roper Center for Public Opinion Research; 2007. Pew Hispanic Center: Pew Hispanic Center Poll: 2007 National Survey of Latinos. (International Communications R ed., 2nd ed. Cornell University, Ithaca, NY: Roper Center for Public Opinion Research; 2007.
123.
go back to reference Robert Wood Johnson Foundation Center for Health Policy: National Latino Health and Immigration survey 2015. 2015. Robert Wood Johnson Foundation Center for Health Policy: National Latino Health and Immigration survey 2015. 2015.
124.
go back to reference Rodriguez N, Flores T, Flores RT, Myers HF, Vriesema CC. Validation of the multidimensional acculturative stress inventory on adolescents of Mexican origin. Psychol Assess. 2015;27:1438–51.PubMed Rodriguez N, Flores T, Flores RT, Myers HF, Vriesema CC. Validation of the multidimensional acculturative stress inventory on adolescents of Mexican origin. Psychol Assess. 2015;27:1438–51.PubMed
125.
go back to reference Phinney JS, Ong AD. Conceptualization and measurement of ethnic identity: current status and future directions. J Couns Psychol. 2007;54:271–81. Phinney JS, Ong AD. Conceptualization and measurement of ethnic identity: current status and future directions. J Couns Psychol. 2007;54:271–81.
127.
go back to reference Olmstead TA, Ostrow CD, Carroll KM. Cost-effectiveness of computer-assisted training in cognitive-behavioral therapy as an adjunct to standard care for addiction. Drug Alcohol Depend. 2010;110:200–7.PubMedPubMedCentral Olmstead TA, Ostrow CD, Carroll KM. Cost-effectiveness of computer-assisted training in cognitive-behavioral therapy as an adjunct to standard care for addiction. Drug Alcohol Depend. 2010;110:200–7.PubMedPubMedCentral
128.
go back to reference Olmstead TA, Sindelar JL, Petry NM. Cost-effectiveness of prize-based incentives for stimulant abusers in outpatient psychosocial treatment programs. Drug Alcohol Depend. 2007;87:175–82.PubMed Olmstead TA, Sindelar JL, Petry NM. Cost-effectiveness of prize-based incentives for stimulant abusers in outpatient psychosocial treatment programs. Drug Alcohol Depend. 2007;87:175–82.PubMed
129.
go back to reference Levine J, Schooler NR. SAFTEE: a technique for the systematic assessment of side effects in clinical trials. Psychopharmacol Bull. 1986;22:343–81.PubMed Levine J, Schooler NR. SAFTEE: a technique for the systematic assessment of side effects in clinical trials. Psychopharmacol Bull. 1986;22:343–81.PubMed
131.
go back to reference Dnofrio G, Hawk KF, Herring AA, Perrone J, Cowan E, McCormack RP, Dziura J, Taylor RA, Coupet E, Edelman EJ, et al. The design and conduct of a randomized clinical trial comparing emergency department initiation of sublingual versus a day extended-release injection formulation of buprenorphine for opioid use disorder: project ED innovation. Contemp Clin Trials. 2021;104:106359. Dnofrio G, Hawk KF, Herring AA, Perrone J, Cowan E, McCormack RP, Dziura J, Taylor RA, Coupet E, Edelman EJ, et al. The design and conduct of a randomized clinical trial comparing emergency department initiation of sublingual versus a day extended-release injection formulation of buprenorphine for opioid use disorder: project ED innovation. Contemp Clin Trials. 2021;104:106359.
132.
go back to reference Miller WaR S. Motivational interviewing: helping people change. New York: Guilford Press; 2013. Miller WaR S. Motivational interviewing: helping people change. New York: Guilford Press; 2013.
133.
go back to reference Bernstein E, Bernstein J, Levenson S. Project ASSERT: an ED-based intervention to increase access to primary care, preventive services, and the substance abuse treatment system. Ann Emerg Med. 1997;30:181–9.PubMed Bernstein E, Bernstein J, Levenson S. Project ASSERT: an ED-based intervention to increase access to primary care, preventive services, and the substance abuse treatment system. Ann Emerg Med. 1997;30:181–9.PubMed
Metadata
Title
Promoting alcohol treatment engagement post-hospitalization with brief intervention, medications and CBT4CBT: protocol for a randomized clinical trial in a diverse patient population
Authors
E. Jennifer Edelman
Oscar F. Rojas-Perez
Charla Nich
Joanne Corvino
Tami Frankforter
Derrick Gordon
Ayana Jordan
Manuel Paris, Jr
Melissa B. Weimer
Brian T. Yates
Emily C. Williams
Brian D. Kiluk
Publication date
01-12-2023
Publisher
BioMed Central
Published in
Addiction Science & Clinical Practice / Issue 1/2023
Electronic ISSN: 1940-0640
DOI
https://doi.org/10.1186/s13722-023-00407-9

Other articles of this Issue 1/2023

Addiction Science & Clinical Practice 1/2023 Go to the issue